SpecialtiesDavid Michael Asmuth, M.D. 
Philosophy of Care
Title:
Specialty:
Center/Program Affiliation:
Address:
1500 21st St.
Sacramento, CA 95811
Phone:
Education:
Chicago, Illinois
M.D. 1985
University of Notre Dame
South Bend, Indiana
B.A. 1977
Internships:
Madison, Wisconsin
1985-86
Residency:
Seattle, Washington
1986-88
Internal Medicine
Fellowships:
Boston, Massachusetts
1989-93
Infectious Diseases
University of Washington-Seattle
Boise, Idaho
1988-89
Infectious Diseases
Board Certifications:
American Board of Internal Medicine, 1988
Professional Memberships:
Infectious Diseases Society of America
International Society of Analytical Cytometry
Veterans Administration Northern California Health Care System-Associate Chief of Staff for Research and Development
Honors and Awards:
Humanism in Medical Education Award - AAMC UTMB nominee, 1999
Select Recent Publications:
Chary A, Winters MA, Eisen R, Knight TH, Asmuth DM, Holodniy M. Quantitation of Hepatitis C Virus RNA in Peripheral Blood Mononuclear Cells from HCV-Monoinfected and HIV/HCV-Coinfected Patients. J Med Virol. 2012 84(3):431-437.
Hubbard JJ, Greenwell-Wild T, Yang J, Lempicki RA, Wahl SM, Asmuth DM, Murphy RL, Pollard RB, Kottilil S. Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with Pegylated interferon-alpha 2a. J Infect Dis. 2012;205:1443–7.
Maniar A, Ellis CE, Asmuth D, Pollard RB, Rutledge J. HIV Infection and Atherosclerosis: Evaluating the Drivers of Inflammation. ,em>Eur J Prev Cardiol. 2012. May 3.
Schunter M, Chu H, Hayes TL, McConnell D, Crawford SS, Luciw PA, Bengmark S, Asmuth DM, Brown J, Bevins CL, Shacklett BL, Critchfield JW. Randomized Pilot Trial of a Synbiotic Dietary Supplement in Chronic HIV-1 Infection. BMC Complement Altern Med. 2012 Jun 29;12(1):84
Asmuth DM, Ma Z-M, Mann S, Knight TH, Yotter T, Albanese A, Melcher GP, Troia-Cancio P, Hayes T, Miller CJ, Pollard RB. Gastrointestinal-Associated Lymphoid Tissue (GALT) Immune Reconstitution in a Randomized Clinical Trial of Raltegravir Versus NNRTI-based Regimens. AIDS 2012: Aug 24;26(13):1625-34
Imamichi H, Degray G, Asmuth DM, Fischl MA, Landay AL, Lederman MM, Sereti I. HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy. AIDS. 2011 Jan 14;252:159-64.
Ellis CL, Ma Z-M, Mann SK, Li C-S, Wu J, Knight TH, Yotter T, Hayes TL, Maniar AH, Troia-Cancio PV, Overman HA, Torok NJ, Albanese A, Rutledge JC, Miller CJ, Pollard RB, Asmuth DM, Molecular Characterization of Stool Microbiota in HIV-Infect Subjects by Panbacterial and Order-Level 16S Ribosomal DNA rDNA Quantification and Correlations with Immune Activation. J Acquir Immune Defic Syndr. 2011 575:363-370, August 15, 2011.
Asmuth DM, Brown EL, DiNubile MJ, Sun X, del Rio C, Harro C, Keefer MC, Kublin JG, Dubey SA, Kierstead LS, Casimiro DR, Shiver JW, Robertson MN, Quirk EK, Mehrotra DV. Comparative Cell-Mediated Immunogenicity of DNA/DNA, DNA/Ad5, or Ad5/Ad5 HIV-1 Clade B gag Vaccine Prime-Boost Regimens. J Infect Dis. 2010 Jan 2011:132-41.
Asmuth DM, Murphy RL, Rosencranz SL, Lertora JJ, Kottilil S, Cramer Y, Chan ES, Schooley RT, Rinaldo CR, Thielman N, Li X-D, Wahl SM, Shore J, Janik J, Lempicki RA, Simpson Y, Pollard RB. Safety, Tolerability and Mechanisms of Antiretroviral Activity of Peginterferon alfa-2a in HIV-1-Mono-infected Subjects: A Phase II Clinical Trial. J Infect Dis. Jun 1, 2010; 20111:1686-96.
Asmuth DM, Goodrich J, Cooper DA, Haubrich R, Rajicic N, Hirschel B, Mayer H, Valdez H. CD4 T-Cell Restoration after 48 Weeks in the Maraviroc Treatment-experienced Trials MOTIVATE 1 and 2. J Acquir Immune Defic Syndr. Aug 1, 2010;544:394-7.
